Screened 2026-09-09 · the tape above runs as of 10:31 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
Albemarle Corporation holds its Markdown at $125.91. The statistical read favours the buyers, held for 17 days.
As held on the ledger · 2026-09-09
Phase
Markdown · caution
Quantitative state
The statistical read favours the buyers, held for 17 days
Price at the screen
$125.91
Valuation
466.33 trailing · 11.15 forward price to earnings
Values screen
PASS· score 88.8
Beta
1.33
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
20.13%
Below 33%
Interest-bearing debt is just 20.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.39%
Below 33%
Cash held in interest-bearing accounts and securities is 0.4% of assets, under the one-third limit.
Pass
Receivables
13.51%
Below 49%
Money owed to the company is 13.5% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OPPORTUNITY: it trades at roughly a 6% discount to our $133.98 fair value, weak competitive moat, 31.10% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 6.4% margin of safety to the base estimate.
Third-party analyst targets: 20 covering, consensus Buy. The average target sits +37% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Lithium boom meets a classic cycle trap
Picture the battery boom as a giant wave that lifts every lithium producer one year and buries half of them the next. Albemarle rides that wave with 33 percent revenue growth, yet it is posting a negative 4 percent profit margin and minus 2 percent return on equity right now. The forward multiple of 9.5 times looks cheap next to a 26 percent margin of safety to our fair value, and the ethical screen clears without issue.
What stands out is the scale in energy storage chemicals at a time when electric vehicles keep taking share. Twenty analysts still cluster around a buy rating with a 196 dollar median target, well above the current 120 dollar price. The business has real volume leverage if lithium demand holds.
The catch is the cycle itself. Low multiples in specialty chemicals often signal peak earnings rather than a bargain, and a weak moat leaves the firm exposed when prices turn. Currency swings and capacity additions elsewhere can erase the apparent discount fast. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ALB trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-07-21Markdown$120.78-22.3%Entry 5
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 22.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-07-18Markdown$155.44+0.0%Entry 4
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-07-17Markdown$155.44+0.0%Entry 3
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 135%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (22 analysts) rates it buy, with a mean price target of $212.
2026-07-03Markdown$155.44+0.0%Entry 2
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markdown$155.44Entry 1
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.